CEBPZOS
gene geneOn this page
Summary
CEBPZOS (CEBPZ opposite strand, HGNC:49288) is a protein-coding gene on chromosome 2p22.2, encoding Protein CEBPZOS (A8MTT3).
Located in mitochondrion.
Source: NCBI Gene 100505876 — RefSeq curated summary.
At a glance
- MANE Select transcript:
NM_001322374
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:49288 |
| Approved symbol | CEBPZOS |
| Name | CEBPZ opposite strand |
| Location | 2p22.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000218739 |
| Ensembl biotype | protein_coding |
| Entrez | 100505876 |
Gene structure
Transcript identifiers
Ensembl transcripts: 44 — 42 protein_coding, 1 protein_coding_CDS_not_defined, 1 retained_intron
ENST00000392061, ENST00000397064, ENST00000397226, ENST00000402297, ENST00000406711, ENST00000438935, ENST00000470216, ENST00000898764, ENST00000898765, ENST00000898766, ENST00000898767, ENST00000898768, ENST00000898769, ENST00000898770, ENST00000898771, ENST00000898772, ENST00000898773, ENST00000898774, ENST00000898775, ENST00000898776, ENST00000898777, ENST00000898778, ENST00000898779, ENST00000898780, ENST00000938662, ENST00000938663, ENST00000938664, ENST00000938665, ENST00000938666, ENST00000938667, ENST00000938668, ENST00000938669, ENST00000938670, ENST00000938671, ENST00000938672, ENST00000938673, ENST00000938674, ENST00000938675, ENST00000938676, ENST00000938677, ENST00000938678, ENST00000938679, ENST00000938680, ENST00000963820
RefSeq mRNA: 4 — MANE Select: NM_001322374
NM_001322373, NM_001322374, NM_001322375, NM_001322376
CCDS: CCDS82435
Canonical transcript exons
ENST00000402297 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001547783 | 37201642 | 37201726 |
| ENSE00001551955 | 37201048 | 37201092 |
| ENSE00001553179 | 37201863 | 37204743 |
| ENSE00003662260 | 37199704 | 37199819 |
| ENSE00003843942 | 37196496 | 37196520 |
Expression profiles
Bgee: expression breadth ubiquitous, 242 present calls, max score 94.25.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 22.1134 / max 156.1556, expressed in 1794 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 19753 | 22.1134 | 1794 |
Top tissues by expression
253 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| hindlimb stylopod muscle | UBERON:0004252 | 94.25 | gold quality |
| right adrenal gland | UBERON:0001233 | 93.29 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 93.28 | gold quality |
| left adrenal gland | UBERON:0001234 | 93.27 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 93.16 | gold quality |
| oviduct epithelium | UBERON:0004804 | 92.78 | gold quality |
| islet of Langerhans | UBERON:0000006 | 92.60 | gold quality |
| muscle of leg | UBERON:0001383 | 92.58 | gold quality |
| gastrocnemius | UBERON:0001388 | 92.55 | gold quality |
| buccal mucosa cell | CL:0002336 | 92.33 | gold quality |
| left ovary | UBERON:0002119 | 92.24 | gold quality |
| calcaneal tendon | UBERON:0003701 | 92.22 | gold quality |
| rectum | UBERON:0001052 | 92.14 | gold quality |
| adrenal gland | UBERON:0002369 | 91.98 | gold quality |
| adrenal tissue | UBERON:0018303 | 91.98 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 91.91 | gold quality |
| right ovary | UBERON:0002118 | 91.53 | gold quality |
| adrenal cortex | UBERON:0001235 | 91.49 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 91.41 | gold quality |
| adenohypophysis | UBERON:0002196 | 91.29 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 91.25 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 91.21 | gold quality |
| right uterine tube | UBERON:0001302 | 91.16 | gold quality |
| body of uterus | UBERON:0009853 | 91.16 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 90.71 | gold quality |
| heart left ventricle | UBERON:0002084 | 90.70 | gold quality |
| lower esophagus | UBERON:0013473 | 90.70 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 90.65 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 90.61 | gold quality |
| prefrontal cortex | UBERON:0000451 | 90.57 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-CURD-135 | yes | 1834.74 |
| E-ANND-3 | yes | 6.79 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
117 targeting CEBPZOS, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-3646 | 100.00 | 73.56 | 5283 |
| HSA-MIR-432-3P | 100.00 | 67.86 | 705 |
| HSA-MIR-4713-3P | 100.00 | 65.92 | 505 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-548P | 99.98 | 72.25 | 3784 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-548N | 99.98 | 71.94 | 4170 |
| HSA-MIR-551B-5P | 99.96 | 71.28 | 3493 |
| HSA-MIR-3658 | 99.96 | 73.87 | 4379 |
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-MIR-493-5P | 99.96 | 72.47 | 2382 |
| HSA-MIR-101-3P | 99.94 | 75.03 | 2230 |
| HSA-MIR-6744-5P | 99.93 | 66.82 | 748 |
| HSA-MIR-10527-5P | 99.91 | 72.28 | 3754 |
| HSA-MIR-1297 | 99.91 | 73.41 | 3162 |
| HSA-MIR-6780A-5P | 99.88 | 66.69 | 2776 |
| HSA-MIR-10395-5P | 99.86 | 67.35 | 676 |
| HSA-MIR-4728-5P | 99.85 | 69.39 | 4718 |
| HSA-MIR-576-5P | 99.84 | 70.46 | 2582 |
| HSA-MIR-548AZ-5P | 99.83 | 69.94 | 3230 |
| HSA-MIR-548T-5P | 99.83 | 69.91 | 3220 |
| HSA-MIR-6785-5P | 99.82 | 68.68 | 4428 |
| HSA-MIR-6756-5P | 99.82 | 67.97 | 2466 |
| HSA-MIR-4659A-3P | 99.80 | 72.62 | 4248 |
| HSA-MIR-4659B-3P | 99.80 | 72.62 | 4248 |
| HSA-MIR-139-5P | 99.80 | 69.50 | 1399 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Cebpzos | ENSMUSG00000062691 |
| rattus_norvegicus | Cebpzos | ENSRNOG00000064368 |
Protein
Protein identifiers
Protein CEBPZOS — A8MTT3 (reviewed: A8MTT3)
Alternative names: CEBPZ antisense RNA 1, CEBPZ opposite strand
All UniProt accessions (1): A8MTT3
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Mitochondrion membrane.
RefSeq proteins (4): NP_001309302, NP_001309303, NP_001309304, NP_001309305 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR037764 | CEBPZOS | Family |
UniProt features (2 total): chain 1, transmembrane region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A8MTT3-F1 | 91.70 | 0.86 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 82 (showing top):
GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN, MILI_PSEUDOPODIA_HAPTOTAXIS_UP, TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP, GOCC_MITOCHONDRIAL_ENVELOPE, GOCC_ORGANELLE_ENVELOPE, chr2p22, LHX9_TARGET_GENES, NKX2_2_TARGET_GENES, MIR616_5P, MIR371B_5P, MIR373_5P, MIR548P, MIR10527_5P, MIR4728_5P, MIR551B_5P
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (3): mitochondrion (GO:0005739), mitochondrial membrane (GO:0031966), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cytoplasm | 1 |
| intracellular membrane-bounded organelle | 1 |
| mitochondrion | 1 |
| mitochondrial envelope | 1 |
| organelle membrane | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
176 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CEBPZOS | RUSF1 | Q96GQ5 | 608 |
| CEBPZOS | ATOSB | Q7L5A3 | 586 |
| CEBPZOS | MTRES1 | Q9P0P8 | 522 |
| CEBPZOS | CCDC127 | Q96BQ5 | 479 |
| CEBPZOS | EXOG | Q9Y2C4 | 461 |
| CEBPZOS | SAMD4B | Q5PRF9 | 453 |
| CEBPZOS | COA7 | Q96BR5 | 446 |
| CEBPZOS | FXYD4 | P59646 | 422 |
| CEBPZOS | TMT1A | Q9H8H3 | 410 |
| CEBPZOS | POLG2 | Q9UHN1 | 394 |
| CEBPZOS | ABRAXAS2 | Q15018 | 377 |
| CEBPZOS | APOO | Q9BUR5 | 370 |
| CEBPZOS | FOXN2 | P32314 | 357 |
| CEBPZOS | RAB20 | Q9NX57 | 353 |
| CEBPZOS | UQCC4 | Q4G0I0 | 352 |
IntAct
8 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TRDN | TMEM223 | psi-mi:“MI:0914”(association) | 0.640 |
| CEBPZOS | H1-4 | psi-mi:“MI:0915”(physical association) | 0.400 |
| rep | CEBPZOS | psi-mi:“MI:0914”(association) | 0.350 |
| NDRG2 | CEBPZOS | psi-mi:“MI:0914”(association) | 0.350 |
| PBXIP1 | CEBPZOS | psi-mi:“MI:0914”(association) | 0.350 |
| SLC39A8 | CEBPZOS | psi-mi:“MI:0914”(association) | 0.350 |
ESM2 similar proteins: A1L2P2, A1XQT2, A5PJ82, A8MTT3, D2H617, D4ACP2, E2R5I0, F6USH3, G1QDE8, G1S9B8, O95139, P04038, P09669, P0CB93, P0CB94, P11951, P80977, Q02367, Q0MQ88, Q0MQ89, Q0MQ90, Q0MQE0, Q0MQE1, Q0Q4Z0, Q28EM2, Q28GF4, Q29259, Q3UIU2, Q4I8P5, Q5BKW8, Q5RK28, Q68EV8, Q78RX3, Q7YRJ8, Q7YRJ9, Q7YRK0, Q7YRK1, Q7YRK2, Q7YRK3, Q7YRK7
Diamond homologs: A8MTT3, Q8BTE5
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
0 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1941 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 2:37201640:A:AG | acceptor_gain | 1.0000 |
| 2:37201641:G:GG | acceptor_gain | 1.0000 |
| 2:37202780:TTA:T | donor_loss | 1.0000 |
| 2:37202781:TAC:T | donor_loss | 1.0000 |
| 2:37202782:A:AC | donor_gain | 1.0000 |
| 2:37202782:ACTT:A | donor_loss | 1.0000 |
| 2:37202782:ACTTG:A | donor_gain | 1.0000 |
| 2:37202783:C:CG | donor_gain | 1.0000 |
| 2:37202783:CTT:C | donor_gain | 1.0000 |
| 2:37202783:CTTG:C | donor_gain | 1.0000 |
| 2:37202783:CTTGC:C | donor_gain | 1.0000 |
| 2:37202861:CCAAA:C | acceptor_gain | 1.0000 |
| 2:37202862:CAAA:C | acceptor_gain | 1.0000 |
| 2:37202862:CAAAC:C | acceptor_gain | 1.0000 |
| 2:37202863:AAA:A | acceptor_gain | 1.0000 |
| 2:37202863:AAAC:A | acceptor_loss | 1.0000 |
| 2:37202864:AA:A | acceptor_gain | 1.0000 |
| 2:37202864:AAC:A | acceptor_loss | 1.0000 |
| 2:37202866:C:CA | acceptor_loss | 1.0000 |
| 2:37202866:C:CC | acceptor_gain | 1.0000 |
| 2:37202867:T:C | acceptor_gain | 1.0000 |
| 2:37202868:T:TC | acceptor_gain | 1.0000 |
| 2:37202869:T:C | acceptor_gain | 1.0000 |
| 2:37202869:T:TC | acceptor_gain | 1.0000 |
| 2:37202943:GCCTT:G | donor_loss | 1.0000 |
| 2:37202944:CCTTA:C | donor_loss | 1.0000 |
| 2:37202945:CTTA:C | donor_loss | 1.0000 |
| 2:37202946:TTACC:T | donor_loss | 1.0000 |
| 2:37202947:TACC:T | donor_loss | 1.0000 |
| 2:37202948:A:AG | donor_loss | 1.0000 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000055694 (2:37204976 A>C), RS1000098043 (2:37213654 T>A,C), RS1000113618 (2:37199207 C>G), RS1000140487 (2:37197054 C>A), RS1000229262 (2:37199423 T>C), RS1000300464 (2:37194574 C>G), RS1000730535 (2:37194781 G>A), RS1000928946 (2:37200884 A>T), RS1001182216 (2:37216175 C>A,T), RS1001199992 (2:37205410 G>A), RS1001349534 (2:37209884 T>A,C), RS1001552730 (2:37198636 G>A), RS1001876418 (2:37205761 C>A,G), RS1001878456 (2:37199803 G>C), RS1001939760 (2:37204383 T>C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
11 total (human), top 11 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Cadmium Chloride | decreases expression, increases abundance | 2 |
| dicrotophos | decreases expression | 1 |
| beta-lapachone | increases expression | 1 |
| jinfukang | affects cotreatment, increases expression | 1 |
| Cadmium | decreases expression, increases abundance | 1 |
| Cisplatin | affects cotreatment, increases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Valproic Acid | increases expression | 1 |
| Aflatoxin B1 | increases expression | 1 |
| Okadaic Acid | decreases expression | 1 |
| Lactic Acid | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.